Comparative safety and efficacy of paracetamol versus non‐steroidal anti‐inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta‐analysis of randomized controlled trials. Issue 7 (15th March 2022)
- Record Type:
- Journal Article
- Title:
- Comparative safety and efficacy of paracetamol versus non‐steroidal anti‐inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta‐analysis of randomized controlled trials. Issue 7 (15th March 2022)
- Main Title:
- Comparative safety and efficacy of paracetamol versus non‐steroidal anti‐inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta‐analysis of randomized controlled trials
- Authors:
- Katsaras, Dimitrios N.
Katsaras, Georgios N.
Chatziravdeli, Vasiliki I.
Papavasileiou, Garyfalia N.
Touloupaki, Maria
Mitsiakos, Georgios
Doxani, Chrysoula
Stefanidis, Ioannis
Dardiotis, Efthimios - Abstract:
- Abstract : Aim: Ibuprofen and indomethacin are the preferred drug treatment for patent ductus arteriosus (PDA) in preterm neonates. The comparative safety and efficacy of paracetamol as an alternative has not yet been well established. The aim of our study was to define the comparative efficacy and safety of paracetamol versus ibuprofen and indomethacin for PDA. Methods: We performed a systematic literature search in PubMed, Scopus and Cochrane databases on randomized controlled trials comparing the efficacy and/or the safety of paracetamol versus ibuprofen and/or indomethacin and meta‐analysed the available data. Results: There were 1718 neonates from 20 eligible studies. Paracetamol did not differ from ibuprofen or indomethacin regarding the primary (odds ratio [OR]: 0.93; 95% confidence interval [CI]: 0.69–1.26, P ‐value: 0.650, when compared to ibuprofen, and OR: 0.78; 95% CI: 0.20–3.02, P ‐value: 0.716, when compared to indomethacin) and overall (OR: 1.17; 95% CI: 0.82–1.66, P ‐value: 0.394, when compared to ibuprofen, and OR: 1.12; 95% CI: 0.58–2.15, P ‐value: 0.733, when compared to indomethacin) PDA closure rates. Paracetamol resulted in significantly reduced risk of oliguria and a tendency towards less gastrointestinal bleeding. Conclusion: There was no significant difference between paracetamol and ibuprofen or indomethacin in the PDA closure rates. However, paracetamol caused fewer adverse effects.
- Is Part Of:
- British journal of clinical pharmacology. Volume 88:Issue 7(2022)
- Journal:
- British journal of clinical pharmacology
- Issue:
- Volume 88:Issue 7(2022)
- Issue Display:
- Volume 88, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 88
- Issue:
- 7
- Issue Sort Value:
- 2022-0088-0007-0000
- Page Start:
- 3078
- Page End:
- 3100
- Publication Date:
- 2022-03-15
- Subjects:
- acetaminophen -- ibuprofen -- indomethacin -- paracetamol -- patent ductus arteriosus
Pharmacology -- Periodicals
Drugs -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2125 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcp.15291 ↗
- Languages:
- English
- ISSNs:
- 0306-5251
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2307.180000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21821.xml